News & Alerts
-
Feb- 2024 -13 February
Global IV & Oral Iron Drugs Market Report 2024: Market to Reach $16.43 Billion by 2029
Research and Markets has released a report titled “Global IV & Oral Iron Drugs Market – Focused Insights 2024-2029” offering…
Read More » -
13 February
Antithrombotic/Anticoagulant Drugs Market Forecasted to Surge to $46.2 Billion by 2028
BCC Research LLC, a leading provider of market intelligence, unveils an optimistic forecast for the Antithrombotic/Anticoagulant Drugs market, estimating its…
Read More » -
12 February
Ozempic Maker Settles With Florida Spa, Clinic Over Cheaper Compounded Versions
Novo Nordisk, a major player in the pharmaceutical industry, recently reached settlements in lawsuits against two defendants: Cosmetic Laser Professionals…
Read More » -
12 February
Novo Nordisk’s Controlling Shareholder Plans To Invest About $7 Billion a Year By 2030
Novo Holdings, the controlling shareholder of Novo Nordisk, a prominent Danish pharmaceutical company known for its focus on obesity and…
Read More » -
9 February
Why Poland is an Appropriate Destination for Breast Augmentation?
Breast augmentation, a procedure to enhance the size and shape of a woman’s breasts, has become increasingly popular worldwide. Poland,…
Read More » -
9 February
New Study Reports How Some Erectile Dysfunction Meds May Affect Alzheimer’s Risk
A recent study published in Neurology suggests that men prescribed drugs to treat newly diagnosed erectile dysfunction (ED) may have…
Read More » -
9 February
U.S. Senate Democrats Grill Pharma CEOs Over High Drug Prices
On Thursday, U.S. Senate Democrats took a hard stance on the issue of prescription drug prices, grilling three prominent pharmaceutical…
Read More » -
9 February
Precision Gerontology: Caring for an Aging Population
It’s often said that there are only two constants in life – death and taxes. While that’s partially true there…
Read More » -
8 February
AstraZeneca’s Portfolio Booms As it Targets 2024 Growth
AstraZeneca PLC is poised for growth in 2024 as its robust portfolio of cancer and rare disease drugs continues to…
Read More » -
7 February
Best Ways to Save on Freestyle Libre 3 Sensor
Freestyle Libre 3 Sensor is a continuous glucose monitoring (CGM) system developed by Abbott. It’s designed to help people with…
Read More »